- Home
- CTNT vs JAGX Comparison
CTNT vs JAGX Comparison
Compare CTNT & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- JAGX
- Stock Information
- Founded
- CTNT 2016
- JAGX 2013
- Country
- CTNT United States
- JAGX United States
- Employees
- CTNT N/A
- JAGX N/A
- Industry
- CTNT
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- CTNT
- JAGX Health Care
- Exchange
- CTNT Nasdaq
- JAGX Nasdaq
- Market Cap
- CTNT 5.0M
- JAGX 8.1M
- IPO Year
- CTNT 2023
- JAGX N/A
- Fundamental
- Price
- CTNT $1.40
- JAGX $9.07
- Analyst Decision
- CTNT Hold
- JAGX
- Analyst Count
- CTNT 1
- JAGX 0
- Target Price
- CTNT N/A
- JAGX N/A
- AVG Volume (30 Days)
- CTNT 32.8K
- JAGX 263.8K
- Earning Date
- CTNT 05-05-2025
- JAGX 05-16-2025
- Dividend Yield
- CTNT N/A
- JAGX N/A
- EPS Growth
- CTNT N/A
- JAGX N/A
- EPS
- CTNT N/A
- JAGX N/A
- Revenue
- CTNT $858,770.00
- JAGX $11,689,000.00
- Revenue This Year
- CTNT N/A
- JAGX $38.22
- Revenue Next Year
- CTNT $25.00
- JAGX $39.96
- P/E Ratio
- CTNT N/A
- JAGX N/A
- Revenue Growth
- CTNT N/A
- JAGX 19.75
- 52 Week Low
- CTNT $1.20
- JAGX $4.02
- 52 Week High
- CTNT $236.16
- JAGX $502.50
- Technical
- Relative Strength Index (RSI)
- CTNT 43.50
- JAGX 47.78
- Support Level
- CTNT $1.26
- JAGX $8.58
- Resistance Level
- CTNT $1.55
- JAGX $13.20
- Average True Range (ATR)
- CTNT 0.13
- JAGX 1.87
- MACD
- CTNT -0.01
- JAGX 0.08
- Stochastic Oscillator
- CTNT 21.31
- JAGX 31.70
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: (i) cargo storage, (ii) freight forwarding, (iii) U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.